Source: Annual Congress 2004 - Complications of lung cancer or its treatment quality of life - prognosis
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dworakowska, M. Lapinski, A. Skibowska, A. Mital, D. Tomaszewski, R. Dworakowski, E. Kazimierska, J. Skokowski, A. Szutowicz, E. Czestochowska (Gdansk, Poland). Alteration in clotting system in non-small cell lung cancer patients. Eur Respir J 2004; 24: Suppl. 48, 570

Member's Comments

No comment yet.

Related content which might interest you: Correlation between the activation of coagulation-fibrinolysis system and prognosis of nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 231s Year: 2001 Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 771s Year: 2006 Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012 Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Targeted therapy in non-small cell lung cancer Source: Breathe 2012; 8: 206-215 Year: 2012 Study on coagulation abnormality and effect of anticoagulation on prognosis in advanced cases of non-small cell lung cancer Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Prognostic factors in non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006 Soluble non-invasive markers in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005 Role of chemokines in resectable non-small cell lung cancer (NSCLC) Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Prognostic factors affecting survival in advanced non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004 Radio(chemo)therapy in locally advanced nonsmall cell lung cancer Source: Eur Respir Rev 2015; 25: 65-70 Year: 2016 Update on nonsmall cell lung cancer Source: Eur Respir Rev 2010 19: 173-185 Year: 2010 Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Physical Activity patients following lung resection for non-small cell lung cancer Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 Proliferative activity of non-small cell lung cancer after induction chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Anticancer treatment for advanced non-small cell lung cancer Source: Breathe 2011; 8: 124-133 Year: 2011 Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021